Home/EpiBiologics/Shyra Gardai, Ph.D.

SG

Shyra Gardai, Ph.D.

Chief Scientific Officer

Therapeutic Areas

Oncology Immunology Autoimmune Disorders

EpiBiologics Pipeline

Drug	Indication	Phase
c-MET Degrading Bispecific Antibody	Oncology (likely various solid tumors)	Preclinical

Leadership Team at EpiBiologics

Ann Lee-Karlon, Ph.D.

Chief Executive Officer and President

Eric Humke, M.D., Ph.D.

Chief Medical Officer

Chief Financial Officer

Jennifer Cygan, Ph.D.

Chief Business Officer

Jim Wells, Ph.D.

Scientific Founder

View full EpiBiologics profile